1文献来源Overman MJ,Lonardi S,Wong KYM,et al.Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair⁃deficient/microsatellite instabilit
1文献来源Le D T,Kim T W,Van Cutsem E,et al.PhaseⅡopen⁃label study of pembrolizumab in treatment⁃refractory,microsatellite instability⁃high/mismatch repair⁃